Compare Moderna, Inc. (MRNA) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Rush Street Interactive Inc — how do they compare? Moderna, Inc. trades at $224.38 (market cap $78.65B), while Rush Street Interactive Inc trades at $18.99 (market cap $2.35B). The key difference: Moderna, Inc. is far larger — about 33.5× Rush Street Interactive Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Rush Street Interactive Inc for 13 Days on average.
| MRNA | RSI | |
|---|---|---|
Market Cap | $78.65B | $2.35B |
Volume | 37,373,437 | 2,219,374 |
Sector | Health | Consumer Cyclical |
52-Week High | $203.46 | $34.52 |
52-Week Low | $22.36 | $15.89 |
Typical Hold Time | 59 Days | 13 Days |
Enterprise Value | $74.80B | $2.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $214.50, up 9.17% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics, with revenue declining from $18.9B in 2022 to $1.92B in 2025. Recent Nasdaq-100 inclusion creates institutional demand, though Citigroup downgraded to Sell citing valuation concerns after a 500% 2026 rally. The company continues beating EPS expectations despite net losses.
Outlook remains bifurcated between technical strength and fundamental challenges. The cancer vaccine pipeline offers growth potential, but persistent losses and high valuations create headwinds. Near-term momentum may continue from index fund inflows, though profitability concerns warrant caution for long-term investors.
RSI trades at $19.32, down 4.55% today, with bearish technical signals from moving averages but neutral oscillators. The company reported mixed quarterly earnings, beating in Q1 and Q2 2026 but missing in Q4 2025. Revenue grew to $1.13B in 2025 with a net income margin of 2.33%, though profitability faces pressure as margins are expected to compress slightly in 2026. Analyst sentiment remains strongly positive with a consensus price target of $34.88, representing significant upside potential from current levels.
The stock presents a compelling opportunity given the substantial analyst upside target, but faces near-term headwinds from technical weakness and margin compression. Key risks include competitive pressures in online gaming and execution challenges in maintaining growth momentum. Institutional buying activity, including BlackRock's $448M investment in August 2026, provides confidence in the long-term thesis despite current price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
